₹ 447.90
-9.10 (-1.99%)
B
Bafna Pharmaceuticals
₹ 447.90
BAFNAPH Financials Summary (Consolidated)
Bafna Pharmaceuticals revenue increased 71.83% quarter-on-quarter to ₹12 Cr in Sep 2019, while net loss narrowed to ₹1 Cr from ₹2 Cr in the previous quarter. EPS for the quarter stood at -₹0.25, increased from -₹0.90 in the previous quarter.
Bafna Pharmaceuticals Financials
Income Statement
In Cr
Balance Sheet
In Cr
Cash Flow
In Cr
Get In-depth View of BAFNAPH Quaterly Results, Balance Sheet, Cashflows & Corporate Action.
BAFNAPH Revenue Growth
All values are in Crores
Revenue
Profit
Loss

Pay Zero Brokerage on Delivery
Open FREE Demat Account
+91
Or Scan the QR Code to download the Dhan App






